Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. [electronic resource]
Producer: 19981026Description: 3270-8 p. digitalISSN:- 0732-183X
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antigens, CD20 -- immunology
- Disease-Free Survival
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Iodine Radioisotopes -- adverse effects
- Lymphoma, B-Cell -- immunology
- Male
- Middle Aged
- Radioimmunotherapy -- adverse effects
- Radiotherapy Dosage
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.